Cargando…
Extracorporeal Delivery of rAAV with Metabolic Exchange and Oxygenation
Over the past decade much progress has been made towards the treatment of disease with recombinant adeno-associated viral vectors, ranging from cancer to muscular dystrophies, and autoimmune diseases to cystic fibrosis. Given inherent challenges of vector delivery we developed a system incorporating...
Autores principales: | Bieber, Scott, Halldorson, Jeffrey B., Finn, Eric, Ahmad, Suhail, Chamberlain, Jeffrey S., Odom, Guy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607836/ https://www.ncbi.nlm.nih.gov/pubmed/23528884 http://dx.doi.org/10.1038/srep01538 |
Ejemplares similares
-
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013) -
Optimization of miR-22 expression cassette for rAAV delivery on diabetes
por: Yang, Li, et al.
Publicado: (2022) -
Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector
por: Arnett, Andrea L. H., et al.
Publicado: (2011) -
Differential effects of two MRI contrast agents on the integrity and distribution of rAAV2 and rAAV5 in the rat striatum
por: Osting, Sue, et al.
Publicado: (2014) -
Intravenous rAAV2/9 injection for murine cochlear gene delivery
por: Shibata, Seiji B., et al.
Publicado: (2017)